Beta-lactam antibiotics and macrolide antibiotics

This page covers all Beta-lactam antibiotics and macrolide antibiotics drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Bacterial cell wall (penicillin-binding proteins) and bacterial ribosome (50S subunit).

Targets

Bacterial cell wall (penicillin-binding proteins) and bacterial ribosome (50S subunit)

Phase 3 pipeline (1)

• Ceftriaxone; Azithromycin; Amoxicilline/clavulanate; Clarithromycin · Bayer · Infectious Disease
  This is a combination of four beta-lactam and macrolide antibiotics that work by inhibiting bacterial cell wall synthesis and protein synthesis to kill or inhibit growth of susceptible bacteria.

Patent intelligence

• beta lactam antibiotics and macrolide antibiotics patent landscape — aggregated cliff calendar, attackable patents, originator estates